USPTO serial 79265623
BIOXIS PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PINO, BRIAN
- Law office
- TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BIOXIS PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and substances; dermatological products; pharmaceutical products for the treatment of acne, keratosis, seborrhea, psoriasis, signs and symptoms of photo-aging; products for the repair and healing of nerve endings; medical products for skin restoration and growth, namely, products injected in or under the skin, in or under mucous membranes, in or under adipose tissues for use as alternatives to a plastic surgery treatment and/or for filling, remodeling, increasing the volume of any part of the body and for skin regeneration; cartilage reconstruction product; disc hernia treatment product; vaccine vector product | ACTIVE | — |
| 010 | Surgical, medical and veterinary apparatus and instruments; syringes for injection of dermatological products; suture material; implant of any kind and for any use and in particular general surgery implants, visceral and parietal surgery implants, implants for reconstructive and aesthetic surgery, cardiovascular implants, dental implants, orthopedic implants; biocompatible materials for medical use including visco-supplementation substances, designed to fill wrinkles and increase volume | ACTIVE | — |
| 042 | Scientific and medical research; design and development of pharmaceutical and therapeutic products; consultancy with respect to the development of implants and prostheses; medical and scientific research in the field of pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2021 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 30, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 30, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 13, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 27, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 27, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 30, 2020 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 30, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 5, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 14, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 6, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 5, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 30, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |